Back to Authors

Dubinsky, Marla C.

A5139145673 | I98704320

Mayo Clinic

Icahn School of Medicine at Mount Sinai

Citations 1

P257 Efficacy and safety up to 3 years of risankizumab in moderately to severely active ulcerative colitis patients: COMMAND interim results

E-Posters | June 23, 2026 | Volume: No volume available | Issue: No issue available | Pages: A240.2-A241

10.1136/gutjnl-2026-bsg.373